Keep up to date with changes by signing up to receive email alerts.
The Medical Research Council (MRC) together with the Biotechnology and Biological Sciences Research Council (BBSRC) are pleased to announce a £8M call for Networks in Vaccines Research.
Proximity to Discovery: Industry Engagement Fund is designed to provide flexible funding for innovative ways to enable the initial development of academic-industry collaborations.
The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards of £250k-£1.2m to institutions, to be used flexibly to support the earliest stages of multiple translational research projects.
Supports translation of fundamental discoveries toward benefits to human health. Funds pre-clinical development and early clinical testing of novel regenerative medicine therapies.
The MRC/NIHR Methodology Research Programme (MRP) is co-funded by the MRC and the Department of Health’s National Institute for Health Research (NIHR)
The Tools and Resources Development Fund (TRDF) aims to pump prime the next generation of tools, technologies and resources that will be required by bioscience researchers.
DPFS scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.
Stratified Medicine is a priority area for the MRC. We currently have significant investment in this area of research. Researchers are now invited to submit outline proposals for funding for the development of further disease-focussed consortia to stratify disease.
The Medical Research Council (MRC) and the South African Medical Research Council (SAMRC) announce partnership grants to address antimicrobial resistance (AMR).